Search for: "Mylan Pharmaceuticals" Results 261 - 280 of 739
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Sep 2016, 6:00 am
Mylan Pharmaceuticals received a huge amount of press in the United States recently. [read post]
29 Aug 2016, 7:34 am by Mark Astarita
Rawstory (let's keep the source in mind) is reporting that Heather Bresch, the CEO of Mylan and next Pharma Bro (Pharma Sis?) [read post]
29 Aug 2016, 4:30 am by Brett Trout
While Mylan, like most large pharmaceutical manufacturers, has spent millions of dollars on lobbyists and political campaign... [read post]
26 Aug 2016, 7:25 am by Lawrence B. Ebert
One potential EpiPen competitor, Teva Pharmaceuticals, failed to obtain regulatory approval, delaying their entry into the market Another competitor, Sanofi, recalled its competing epinephrine delivery device because it may be delivering in incorrect dosage. [read post]
28 Jun 2016, 6:41 am by Dennis Crouch
., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
18 May 2016, 8:19 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 9:00 pm by Dennis Crouch
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1]  On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
3 May 2016, 1:42 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
30 Mar 2016, 9:59 pm by Patent Docs
Mylan Laboratories Ltd. et al. 1:15-cv-00942; filed October 19, 2015 in the District Court of Delaware • Plaintiffs: Fresenius Kabi USA, LLC; Fresenius Kabi Deutschland GmbH • Defendants: Mylan Laboratories Ltd.; Mylan Inc.; Agila Specialties Inc.; Mylan Pharmaceuticals Inc. [read post]
17 Mar 2016, 2:45 am by Dennis Crouch
by Dennis Crouch President Obama has announced his nomination of Merrick Garland to become the next Supreme Court Justice. [read post]